Exelixis | Biaya Penjualan



Cost Of Sales Perubahan Tanggal
Acadia Pharmaceuticals USD 20.73M 342K 2025-06
Agios Pharmaceuticals USD 1.7M 617K 2025-06
Amgen USD 3.01B 406M 2025-06
AstraZeneca USD 2.47B 232M 2025-06
Bayer EUR 4.36B 1.26B 2025-06
BioMarin Pharmaceutical USD 154.94M 3.38M 2025-06
Bristol-Myers Squibb USD 3.37B 339M 2025-06
Cytokinetics 112.55M 12.71M 2025-06
Eisai JPY 42.6B 2B 2025-06
Eli Lilly USD 2.45B 223.6M 2025-06
Exelixis USD 19.47M 298K 2025-07
Genmab DKK 57M 15M 2025-06
Glaxosmithkline GBP 2.52B 199M 2024-12
Incyte USD 78.77M 10.96M 2025-06
Ionis Pharmaceuticals USD 4.15M 3.15M 2025-06
MacroGenics USD 5.49M 3.62M 2024-12
Merck USD 2.82B 53M 2025-06
Moderna USD 119M 29M 2025-06
Neurocrine Biosciences USD 11.3M 2.1M 2025-06
Novartis USD 3.32B 95M 2025-06
Pfizer USD 4.99B 2.4B 2025-06
Sanofi EUR 2.27B 1.81B 2024-12
Takeda JPY 384.68B 2.6B 2025-06
Ultragenyx Pharmaceutical USD 23M 5.66M 2025-06
Xencor 61.66M 50.95M 2025-06


Exelixis Biaya Penjualan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Aug 2025.